Wolf, Benita
Zimmermann, Stefan http://orcid.org/0000-0002-3562-0918
Arber, Caroline
Irving, Melita
Trueb, Lionel
Coukos, George
Article History
First Online: 16 January 2019
Compliance with Ethical Standards
: Institutional Review Board approval was not required because this is a review of the literature.
: The authors of this manuscript declare relationships with the following companies: Prof. George Coukos, Dr Lionel Trueb, Dr Stefan Zimmermann, Dr Benita Wolf, Dr Melita Irving and Prof. Carline Arber are co-investigators in Iovance and Kite Pharma sponsored clinical studies at CHUV, Lausanne. Prof. Caroline Arber receives royalties from Cell Medica. Prof. Carline Arber has one patent issued in the field of engineered T-cell therapies licensed to Cell Medica in 2016. Prof. Caroline Arber has two provisional patent applications filed in the field of engineered T-cell therapies. Prof. Caroline Arber received consulting fees from Kite/Gilead.
: The authors state that this work has not received any funding.
Free to read: This content has been made available to all.